Your Ear Wax Might Hold Clues to Early Parkinson's, Study Finds
The earlier Parkinson's disease is spotted, the better – for patients, their loved ones, and scientists working toward treatments or a cure.
Now, a new study has found that volatile organic compounds (VOCs) in earwax could carry chemical signals of the neurological disease.
The work builds on earlier findings suggesting that Parkinson's subtly alters body odor, through changes in sebum, the oily substance that naturally moisturizes our hair and skin.
The problem with trying to analyze sebum on the skin is that its exposure to air and the external environment makes it less reliable for clinical testing. Scientists led by a team from Zhejiang University wanted to take a look at ear wax – which is better protected.
Related: Caffeine Flips a Cellular Switch That May Slow Aging, Scientists Discover
"Early diagnosis and intervention are crucial for Parkinson's disease treatment," write the researchers in their published paper. "This study proposes a diagnostic model… that analyzes VOCs from ear canal secretions."
Scientists think those VOCs can be altered by inflammation, cell stress, and neurodegeneration in the brain. With the right tests, the team hypothesized that subtle signals for Parkinson's could show up in the ears.
The researchers took ear canal swabs from 209 study participants, 108 of whom had been given a Parkinson's disease diagnosis. By charting differences in earwax composition between people with and without Parkinson's, four VOCs stood out: ethylbenzene, 4-ethyltoluene, pentanal, and 2-pentadecyl-1,3-dioxolane.
These could potentially be used to identify Parkinson's in the future, acting as a foundation around which tests can be developed. First, though, this same analysis needs to be run on larger groups of people over longer periods of time.
The team then also trained an AI dataset using the same VOC data, producing a tool called an artificial intelligence olfactory system (AIO) that achieved a 94.4 percent accuracy rate in identifying people from the study with Parkinson's – a promising start, but only on a small sample of people so far.
"The AIO based analytical system underscores its potential for use in bedside medical diagnostic devices, aiding in earlier and more effective treatment for Parkinson's disease patients," write the researchers.
Current methods of diagnosing Parkinson's can involve a combination of clinical assessments and brain scans. The new research could potentially lead to a simple ear swab test that could make this diagnostic screening process quicker, cheaper, and capable of picking up Parkinson's earlier.
The findings could also help ongoing study to understand how Parkinson's gets started and how it might be stopped. Identified VOC changes could possibly be used as a chemical fingerprint, identifying other changes happening because of – or perhaps leading to – the disease.
"The next step is to conduct further research at different stages of the disease, in multiple research centers and among multiple ethnic groups, in order to determine whether this method has greater practical application value," says biochemist Hao Dong, from the Nanjing University of Aeronautics and Astronautics.
The research has been published in Analytical Chemistry.
An Early Warning Sign of Dementia Risk May Be Keeping You Up at Night, Study Says
Caffeine Flips a Cellular Switch That May Slow Aging, Scientists Discover
People Are Trying Nicotine Gum For Long Covid – Could It Treat Brain Fog?
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
USA Today
a day ago
- USA Today
'The Cobra' Dave Parker prayed to live one more month. MLB legend's legacy lives on.
Dave Parker, his mind still sharp but his body failing, kept pleading. One more month, he prayed. Please, let him be healthy enough to get to Cooperstown, New York, to be inducted July 27 into Baseball's Hall of Fame. If not, at least keep him alive so he could hear his son present his speech. He fought so courageously since hearing the news in December that he was elected to the Hall of Fame. He was in and out of physical rehab centers these past six months, losing part of his leg battling this dreadful Parkinson's disease, leaving him confined to a wheelchair. DAVE PARKER: Social media reacts to MLB, Pirates legend's death Two weeks ago, when he left his last rehab center, he was informed nothing more could be done. Hospice intervened. And on Saturday morning, the man they called "The Cobra," was gone. Parker was 74. 'Man, I am crushed," former Oakland Athletics teammate Dave Stewart, one of Parker's closest friends, told USA TODAY Sports. 'He's one of the greatest teammates I've ever had. He had such a presence when he walked into the room. 'He was always the biggest in the room with his size (6-foot-3, 230 pounds)," Stewart said, 'but when you add in his personality, he's suddenly 7 feet tall. Just an unbelievable human being and was so charismatic. Everyone loved him." Barry Meister, Parker's long-time agent, called him one of the greatest personalities in baseball history. 'There was no player in baseball with more magnetism than Dave Parker," Meister said. 'The hair on your arms would stand up when he walked into that room. Everyone was aware that The Man had arrived." Parker, the former MVP, seven-time All-Star, three-time Gold Glove winner, two-time batting champion and two-time World Series champion, was nearly as well-known for his swagger and friendly braggadocio as his accomplishments. He created the phrase: 'When the leaves turn brown, I'll be wearing the batting crown." And he would drop: "The sun is going to shine, the wind is going to blow, and Dave is going to go 4-for-4.' He once wore a Star of David necklace, and when asked about it since he wasn't Jewish, he said, 'I'm a David. And I'm a star" When notified in December that he and Dick Allen were voted in by the Classic Baseball Era Committee into the Hall of Fame, his initial reaction was, 'Why did it take so long?" Few in the game of baseball had Parker's personality. He was one of the first professional athletes to wear an earring, a two-carat diamond earring. He was the first baseball player to earn $1 million per season. And he was among the first who was unafraid to bring a powerful personality into a clubhouse. 'He probably had more impact on young players," former Cincinnati Reds teammate Eric Davis said in a statement, 'than any player I've ever been around.' Davis was too distraught to talk, heartbroken that his close friend wouldn't be in Cooperstown. So many friends and family members already planned trips, but even without Parker's presence, most plan to still go, making sure everyone is aware of the impact he had on their lives. Kellye, Parker's wife, expressed to many of them Saturday how terribly difficult life has been for Parker these past few months. They're comforted knowing he is now in a better place. No more pain. No more doctors. No more Parkinson's. 'He was having such a hard time," Stewart said. 'He had the ability to stand up, but not stand up for long periods of time. I remember when I talked to him after he got elected, I told him how happy I was for him, that it was long overdue, and how it should have happened long ago. 'All he could really say is, 'Thank you Stew. I appreciate it. I love you brother.' 'I knew he was happy, but when you have Parkinson's, you can't really tell the emotion in people." Parker was diagnosed in 2012, and his family chooses to remember the good times: the healthy Parker, the vibrant Parker, and, oh, the hysterical Parker. 'He was always so funny," Stewart said. 'He had you laughing all day. Parker had all of the leadership qualities, but he knew how to keep a clubhouse loose. In the worst of times, he always found something inspiring to say. In your personal worst of times, he would always make you laugh at yourself." Said Meister: 'He was the funniest guy who ever played the game. He always had insults." The last time Parker saw Stewart, he noticed that Stewart was wearing a black shirt, black pants and a black jacket, blending in with his skin color, and blurted out: 'Man, go put some clothes on! Why you walking around here naked?" Oh, and he had nicknames for everyone. Pitcher Greg Cadaret: 'Dippy," for his big chin. Catcher Terry Steinbach: 'Home plate face." Pitcher Dennis Eckersley: 'Pretty Pony." 'I remember the time he and John Candelaria met up one night in spring training," Meister said, 'and they really got after it. They hit the town hard. Well, Dave comes in the next day, and goes to sleep on the trainer's table. 'They wanted him to pinch-hit late in the game, so they woke him up, he goes to the plate, and he hits this monstrous home run. The reporters asked him after the game, 'What did you hit Dave? Was that a fastball? A curveball? What was it?' 'Dave says, 'Well, I couldn't really see. It looked like the guy was throwing three baseballs at once. So, I just swung at the middle one.' That was Parker, always full of life, always colorful, and oh, so talented. He hit 22 home runs with a team-leading 97 RBIs when he helped lead the A's to the 1989 World Series. He was 38 years old. 'They just don't make them like that anymore," Meister said. 'They really don't. He's one-of-a-kind. Believe me, everybody in baseball took a loss for this one." 'Yes," says Stewart, 'but we're all better for having known him, and being such good friends with him. 'He will never be forgotten." Follow Nightengale on X: @Bnightengale
Yahoo
3 days ago
- Yahoo
Your Ear Wax Might Hold Clues to Early Parkinson's, Study Finds
The earlier Parkinson's disease is spotted, the better – for patients, their loved ones, and scientists working toward treatments or a cure. Now, a new study has found that volatile organic compounds (VOCs) in earwax could carry chemical signals of the neurological disease. The work builds on earlier findings suggesting that Parkinson's subtly alters body odor, through changes in sebum, the oily substance that naturally moisturizes our hair and skin. The problem with trying to analyze sebum on the skin is that its exposure to air and the external environment makes it less reliable for clinical testing. Scientists led by a team from Zhejiang University wanted to take a look at ear wax – which is better protected. Related: Caffeine Flips a Cellular Switch That May Slow Aging, Scientists Discover "Early diagnosis and intervention are crucial for Parkinson's disease treatment," write the researchers in their published paper. "This study proposes a diagnostic model… that analyzes VOCs from ear canal secretions." Scientists think those VOCs can be altered by inflammation, cell stress, and neurodegeneration in the brain. With the right tests, the team hypothesized that subtle signals for Parkinson's could show up in the ears. The researchers took ear canal swabs from 209 study participants, 108 of whom had been given a Parkinson's disease diagnosis. By charting differences in earwax composition between people with and without Parkinson's, four VOCs stood out: ethylbenzene, 4-ethyltoluene, pentanal, and 2-pentadecyl-1,3-dioxolane. These could potentially be used to identify Parkinson's in the future, acting as a foundation around which tests can be developed. First, though, this same analysis needs to be run on larger groups of people over longer periods of time. The team then also trained an AI dataset using the same VOC data, producing a tool called an artificial intelligence olfactory system (AIO) that achieved a 94.4 percent accuracy rate in identifying people from the study with Parkinson's – a promising start, but only on a small sample of people so far. "The AIO based analytical system underscores its potential for use in bedside medical diagnostic devices, aiding in earlier and more effective treatment for Parkinson's disease patients," write the researchers. Current methods of diagnosing Parkinson's can involve a combination of clinical assessments and brain scans. The new research could potentially lead to a simple ear swab test that could make this diagnostic screening process quicker, cheaper, and capable of picking up Parkinson's earlier. The findings could also help ongoing study to understand how Parkinson's gets started and how it might be stopped. Identified VOC changes could possibly be used as a chemical fingerprint, identifying other changes happening because of – or perhaps leading to – the disease. "The next step is to conduct further research at different stages of the disease, in multiple research centers and among multiple ethnic groups, in order to determine whether this method has greater practical application value," says biochemist Hao Dong, from the Nanjing University of Aeronautics and Astronautics. The research has been published in Analytical Chemistry. An Early Warning Sign of Dementia Risk May Be Keeping You Up at Night, Study Says Caffeine Flips a Cellular Switch That May Slow Aging, Scientists Discover People Are Trying Nicotine Gum For Long Covid – Could It Treat Brain Fog?
Indianapolis Star
3 days ago
- Indianapolis Star
IU School of Medicine opens $230 million education, research building amid NIH cuts
As medical schools around the country face potentially drastic cuts in federal funding for research, the IU School of Medicine unveiled a $230 million new Medical Education and Research Building on June 27. The 11-story building, which will officially open to IU medical students Aug. 4, houses new classrooms, an anatomy lab, a surgical skills center, dedicated community spaces and an eight-story research tower. Construction for the project began in late 2022, and is part of the new Indy Health District. IU Health funded $145 million of the project. In recent months President Donald Trump's plan to trim $18 billion of the National Institutes of Health's budget next year have left several research universities unsure of their futures. The IU School of Medicine, which touts itself as the largest medical school in the U.S., was granted more than $248 million by the NIH for research in 2024. Thursday IUSM Dean Jay Hess said that while the potential for funding cuts worries him, he remains confident in the value of the medical school's research. In addition to medical breakthroughs, IU estimates it created $635 million of economic activity and more than 2,400 jobs in Indiana last year thanks to its NIH-funded research. 'I think everyone in academic medicine right now is really, really concerned,' Hess said. 'I think that we're really trying to focus on, you know, 'What is the output of the research that we do?' And I have seen firsthand as a dean, clinical trials and medical research is actually — people are alive who would have died.' Hess said the lab space in the building, located on 14th Street west of Senate Avenue, will likely be dedicated to neuroscience research. The facility could continue work by the Indiana Alzheimer's Disease Research Center, which has been awarded more than $50 million in NIH funding, as well as research on Parkinson's disease or brain cancers. The facility will also incorporate new medical technologies into the classrooms, replacing many classrooms located in the former medical education building constructed in 1958. The new building includes spaces for students to learn how to practice telemedicine, work in settings that mirror operating rooms, perform ultrasounds on simulated patients and more. Students and staff said the new space would promote peer relationships for medical students, with designated spaces for the medical school's 12 'Professional Learning Communities.' Those learning communities help students support one another in the challenging environment of medical school, said Myke Spencer, a fourth-year medical student. 'I think the learning communities can be like small pods for students to be in smaller groups to collaborate and learn and feel kind of like a family,' Spencer said.
